The Welch Allyn RETeval-DR Electroretinograph is designed for healthcare providers who want to improve management of their patients with diabetes. In just three minutes, you can objectively screen for vision-threatening diabetic retinopathy (VTDR) wherever patients receive care. Welch Allyn RETeval-DR Electroretinograph enables efficient, comfortable, non-mydriatic screening for VTDR that improves patient compliance to help preserve vision in your patients with diabetes.
No dilation required, enhancing patient comfort
Short test time—only three minutes per patient
No interpretation and minimal training necessary
Immediate results provided on the device and in a PDF report
Portable, handheld device goes wherever patients with diabetes receive care
Welch Allyn | Medical Devices & Equipment
Welch Allyn Australia services the South Pacific region including Australia, New Zealand and the Pacific Islands.